tetano
Editor, Senior Moderator
Vopr Virusol. 2019;64(1):5-11. doi: 10.18821/0507-4088-2019-64-1-5-11.
[h=1][Adjuvants of influenza vaccines: new possibilities of using sulphated polysaccharides from marine brown algae.][/h] [Article in Russian]
Kuznetsova TA[SUP]1[/SUP], Persiyanova EV[SUP]1,[/SUP][SUP]2[/SUP], Zaporozhets TS[SUP]1[/SUP], Besednova NN[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The review article presents the characteristics of the main adjuvant groups (mineral salts of aluminum, synthetic squalenebased adjuvants - MF59 and AS03, CpG-oligodeoxynucleotides, virosomes, polyoxidonium, sovidone) included in the licensed influenza vaccine. The main mechanisms of adjuvant action, advantages and disadvantages of these adjuvants are shown. The vaccines adjuvants in the phase of experimental studies and clinical trials (ISCOMs, Advax?, chitosan) are described too. Particular attention is paid to sulfated polysaccharides (fucoidans) from marine brown algae as vaccine adjuvants. Numerous results of their application in compositions of experimental vaccines are presented. The prospects of sulfated polysaccharides using in the design of influenza vaccines are estimated. These prospects are determined by high biocompatibility, low toxicity and good tolerance of the human body to fucoidans, as well as mechanisms of their adjuvant activity. Sulfated polysaccharides are agonists of toll-like receptors of innate immunity cells and powerful inducers of the cellular and humoral immune response, which is important for the development of influenza vaccines. The review is based on the information presented in the bibliographic and abstract databases of scientific publications, search engines and publishers: RSCI, Web of Science, Scopus, MEDLINE, Google Scholar, PubMed, Springer Nature, Elsevier and others.
[h=4]KEYWORDS:[/h] adjuvants; fucoidans; influenza virus; review; sulfated polysaccharides; vaccines
PMID: 30893523 DOI: 10.18821/0507-4088-2019-64-1-5-11
[h=1][Adjuvants of influenza vaccines: new possibilities of using sulphated polysaccharides from marine brown algae.][/h] [Article in Russian]
Kuznetsova TA[SUP]1[/SUP], Persiyanova EV[SUP]1,[/SUP][SUP]2[/SUP], Zaporozhets TS[SUP]1[/SUP], Besednova NN[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The review article presents the characteristics of the main adjuvant groups (mineral salts of aluminum, synthetic squalenebased adjuvants - MF59 and AS03, CpG-oligodeoxynucleotides, virosomes, polyoxidonium, sovidone) included in the licensed influenza vaccine. The main mechanisms of adjuvant action, advantages and disadvantages of these adjuvants are shown. The vaccines adjuvants in the phase of experimental studies and clinical trials (ISCOMs, Advax?, chitosan) are described too. Particular attention is paid to sulfated polysaccharides (fucoidans) from marine brown algae as vaccine adjuvants. Numerous results of their application in compositions of experimental vaccines are presented. The prospects of sulfated polysaccharides using in the design of influenza vaccines are estimated. These prospects are determined by high biocompatibility, low toxicity and good tolerance of the human body to fucoidans, as well as mechanisms of their adjuvant activity. Sulfated polysaccharides are agonists of toll-like receptors of innate immunity cells and powerful inducers of the cellular and humoral immune response, which is important for the development of influenza vaccines. The review is based on the information presented in the bibliographic and abstract databases of scientific publications, search engines and publishers: RSCI, Web of Science, Scopus, MEDLINE, Google Scholar, PubMed, Springer Nature, Elsevier and others.
[h=4]KEYWORDS:[/h] adjuvants; fucoidans; influenza virus; review; sulfated polysaccharides; vaccines
PMID: 30893523 DOI: 10.18821/0507-4088-2019-64-1-5-11